NEW PRODUCTS/PRODUCT NEWS

摘要

Smith & Nephew Biologies & Spine has launched a new system for performing transforaminal epidural injections. The TRUCATH~(TM) Spinal Injection System is designed to help reduce the risks associated with epidural pain management procedures. The design enables the physician to position the needle outside the bony structure of the spine, accurately delivering the catheter to the correct transforaminal entry point and reducing the potential for venous and arterial trespass. The TRUCATH device has been licensed to Smith & Nephew in an exclusive global agreement with Laurimed, a privately owned medical device company based in Redwood City, California. It has received FDA clearance for use in injections into the epidural space. The new injection system is available immediately in the United States.